About Publications

Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Review of NASA's Evidence Reports on Human Health Risks ... Released: January 06, 2017
    The National Academies of Science, Engineering and Medicine at the request of the National Aeronautics & Space Administration (NASA) and with guidance from the National Academies’ Standing Committee on Aerospace Medicine and the Medicine of Extreme Environments, has established a committee to review NASA’s Evidence Reports on Human Health Risks. These evidence reports focus on human health risks for long-duration and exploration spaceflights. To review the eight NASA evidence reports that were examined in 2016, the National Academies assembled a 13-member committee with multidisciplinary expertise.
  • Exploring Strategies to Improve Cardiac Arrest Survival ... Released: December 20, 2016
    Cardiac arrest often strikes seemingly healthy individuals without warning and without regard to age, gender, race, or health status. Following the release of the 2015 Institute of Medicine (IOM) consensus report, Strategies to Improve Cardiac Arrest Survival: A Time to Act, eight sponsors asked the Health and Medicine Division to hold a workshop to assemble diverse stakeholders who would explore the barriers and opportunities for advancing the IOM recommendations.
  • Enhancing BioWatch Capabilities Through Technology and ... Released: December 05, 2016
    In response to the 2015 Government Accountability Office (GAO) report Biosurveillance: DHS Should Not Pursue BioWatch Upgrades or Enhancements Until System Capabilities Are Established, the Department of Homeland Security (DHS) requested that the National Academies of Sciences, Engineering, and Medicine conduct a workshop to further explore the findings of the 2015 GAO report and discuss the impact these findings may have with regard to the future development of the technical capabilities of the BioWatch program.
  • Strengthening the workforce to Support Community Living and ... Released: November 22, 2016
    As the demographics of the United States shift toward a population that is made up of an increasing percentage of older adults and people with disabilities, the workforce that supports and enables these individuals is also shifting to meet the demands of this population. To better understand how the nation’s workforce can be strengthened to meet these demands, the Health and Medicine Division and the Division of Behavioral and Social Sciences and Education of the National Academies of Sciences, Engineering, and Medicine, convened a public workshop with support from multiple sponsors.
  • Developing Multimodal Therapies for Brain Disorders ... Released: November 18, 2016
    Califf was the keynote speaker at a workshop on multimodality therapies for brain disorders, convened by the National Academies of Sciences, Engineering, and Medicine’s Forum on Neuroscience and Nervous Systems Disorders. The workshop brought together key stakeholders to examine the general principles underlying multimodal therapies and to explore challenges, potential barriers, and opportunities for their development from multiple perspectives, including scientific, clinical, regulatory, and financial. These proceedings chronicle the presentations and discussions at the workshop.
  • Pain Management and Prescription Opioid-Related Harms ... Released: November 04, 2016
    The Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse was tasked with preparing a report that will identify actions that the U.S. Food and Drug Administration (FDA) and others can take to address the opioid epidemic while taking into account individual need for pain control, including FDA’s development of a formal method to incorporate the broader public health impact of prescription opioids into its future approval decisions regarding opioids.
  • Deriving Drug Discovery Value from Large-Scale Genetic ... Released: September 09, 2016
    Utilizing genetic and phenotypic information collected and stored in bioresources has the potential to enable more efficient drug discovery and precision medicine.
  • Neuroscience Trials of the Future: Proceedings of a Workshop ... Released: August 19, 2016
    On March 3–4, 2016, the National Academies of Sciences, Engineering, and Medicine’s Forum on Neuroscience and Nervous System Disorders held a workshop in Washington, DC, bringing together key stakeholders to discuss opportunities for improving the integrity, efficiency, and validity of clinical trials for nervous system disorders.
  • Exploring Disaster Risk Reduction Through Community Level ... Released: August 10, 2016
    On April 21, 2016, the Health and Medicine Division of the National Academies of Sciences, Engineering, and Medicine convened a workshop during the 2016 Preparedness Summit, a national conference on public health preparedness.
  • The Nation's Medical Countermeasure Stockpile ... Released: June 28, 2016
    The National Academies of Sciences, Engineering, and Medicine established a standing committee of experts to help inform decision making by CDC DSNS, including experts in state and local public health, medical countermeasure (MCM) production, warehouse and product distribution, logistics management, pharmaceutical supply chain modeling, emergency medical services, emergency medicine, risk communications, and FDA regulatory issues.